KYMR
Kymera Therapeutics Inc
$34.35
Earnings Summary
Revenue | $47.89Mn |
Net Profits | $-14.37Mn |
Net Profit Margins | -30.01% |
Highlights
Kymera Therapeutics Inc’s revenue jumped 196.7% since last year same period to $47.89Mn in the Q4 2023. On a quarterly growth basis, Kymera Therapeutics Inc has generated 912.8% jump in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit jumped 57.8% since last year same period to $-14.37Mn in the Q4 2023. On a quarterly growth basis, Kymera Therapeutics Inc has generated 72.82% jump in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin jumped 85.78% since last year same period to -30.01% in the Q4 2023. On a quarterly growth basis, Kymera Therapeutics Inc has generated 97.32% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Kymera Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.72 |
EPS Estimate Current Year | -0.72 |
Highlights
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.72 - a -80% fall from last quarter’s estimates.
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.72.
Key Ratios
Key ratios of the Kymera Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.25 |
Highlights
Kymera Therapeutics Inc’s earning per share (EPS) jumped 58.33% since last year same period to -0.25 in the Q4 2023. This indicates that the Kymera Therapeutics Inc has generated 58.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.64 | -0.9 | -40.63% |
2023-08-03 | -0.71 | -0.67 | 5.63% |
2024-02-22 | -0.4 | -0.25 | 37.5% |
2023-05-04 | -0.68 | -0.7 | -2.94% |
₹0 US Stocks a/c Opening Fee